Clinical Trials Browser

Phase EARLY_PHASE1 × Immunotherapy, Active × 1 year × Clear all

NCT03631043 2025-12-19

Personalized Vaccine in Treating Patients With Smoldering Multiple Myeloma

Phase EARLY_PHASE1 Completed

Smoldering Multiple Myeloma